Literature DB >> 20163986

Patient expectations and preferences for follow-up after treatment for lung cancer: a pilot study.

Meinir Krishnasamy1, Anna Ugalde, Mariko Carey, Mary Duffy, Tracey Dryden.   

Abstract

INTRODUCTION: There is no robust evidence to indicate the most appropriate models of follow-up care for patients who have completed treatment for lung cancer. This pilot study aimed to assess expectations and preferences for follow-up care in a sample of patients who had completed treatment for lung cancer.
METHOD: Thirty-one patients who had completed treatment for primary lung cancer were recruited. A 13 item self-report survey was developed to elicit patient's preferences and expectations for follow-up. Participants completed the developed survey and clinical and demographic variables were collected.
RESULTS: Factors scored as extremely important by over 80% of respondents focused on care coordination: Being able to see the same doctor or health care professional at each visit (24/83%); Knowing which doctor or nurse to contact if queries arise between follow-up appointments (23/82%); and Knowing the patient can book an appointment or contact a health care professional involved in their care regarding health concerns between visits (25/89%). Patients were supportive of nurse-led follow-up when offered in the context of a model of shared care (21/78%).
CONCLUSION: This study offers new insight into the expectations and preferences for follow-up of patients with lung cancer, with participants indicated preference for intensive follow-up after the completion of treatment.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20163986     DOI: 10.1016/j.ejon.2010.01.002

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  1 in total

1.  Motivation to take part in integrated care-an assessment of follow-up home visits to elderly persons.

Authors:  Ulf Hjelmar; Carsten Hendriksen; Kirsten Hansen
Journal:  Int J Integr Care       Date:  2011-08-31       Impact factor: 5.120

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.